JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263246

Human LRRC41 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LRRC41 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1.

View Alternative Names

Leucine rich repeat containing 41, Leucine rich repeat containing protein 41, MUF1, PP7759, elongin BC interacting leucine rich repeat protein

1 Images
Sanger Sequencing - Human LRRC41 knockout HeLa cell lysate (AB263246)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRRC41 knockout HeLa cell lysate (AB263246)

Homozygous : 1 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263246-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LRRC41 knockout HeLa cell lysate", "number":"AB263246-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263246-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
LRRC41
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The LRRC41 protein also known as LRR41 or Leucine-Rich Repeat Containing Protein 41 has distinct mechanical roles in cellular processes. Structurally this protein consists of several leucine-rich repeats that facilitate protein-protein interactions. It has a molecular mass of approximately 59 kDa. LRRC41 is widely expressed in human tissues especially in the brain and heart indicating a broad functional importance in these areas.
Biological function summary

LRRC41 plays an essential role in cellular signaling and regulation. It may function as part of larger protein complexes facilitating various regulatory functions. The protein contributes significantly to the regulation of cell cycle and apoptosis among other cellular processes. Its interactions within the cell modulate the signaling pathways that control these vital processes enabling the cell to respond to different stimuli effectively.

Pathways

The LRRC41 protein is involved in the modulation of the MAPK signaling pathway. This pathway is important for transducing extracellular signals into intracellular responses and it is important in cell growth and differentiation. LRRC41 interacts with proteins within this pathway such as RAF1 and MEK to influence signal transduction events. Its involvement in these pathways highlights its role in maintaining cellular homeostasis and responding to environmental changes.

LRRC41 has been implicated in various conditions including cancer and neurodegenerative disorders. In cancer its altered expression can affect cell proliferation pathways linking it to the progression of certain tumors. In neurodegenerative diseases LRRC41 may interact with proteins involved in cellular stress responses such as huntingtin in Huntington's disease. These associations emphasize the relevance of LRRC41 in both research and clinical settings as understanding its role could lead to therapeutic advancements.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com